NextBio, a developer of software platform that enables life science researchers to search, discover and share knowledge locked within public and proprietary data, has signed a license agreement with UCB for NextBio Enterprise.
Subscribe to our email newsletter
NextBio Enterprise offers life sciences organisations tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.
Saeid Akhtari, co-founder and CEO of NextBio, said: “UCB is one of the biopharmaceutical companies, with operations in Europe, the US and Asia. We are very pleased that they are adopting the Enterprise version of the NextBio platform as an integral part of their research and development efforts.
“UCB’s adoption of NextBio Enterprise will enable its scientists to gain unique insights from data created by diverse high-throughput technologies.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.